Recursion said it earned its latest milestone payout by identifying differentiated, oral small molecule leads against a ...

Q1 2025 Earnings Call Transcript May 5, 2025 Recursion Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is ...

Recursion Pharmaceuticals could benefit from FDA’s AI shift despite risks, with scalable tech and long-term potential. Find ...

Evidently in the mood for some spring cleaning, Salt Lake City’s Recursion is clearing out a chunk of its pipeline as it ...

Revenue: Total revenue, consisting primarily of revenue from collaboration agreements, was $15 million for the first quarter ...

and program-specific updates. Management maintained a confident tone, particularly in discussing the Recursion Operating System's advancements and partnership achievements. The tone was consistent ...

Recursion and Sanofi advanced their fourth partnered program through a significant discovery ... This aligns closely with our fundamental goal of using AI and automation to make drug discovery ...

Q1 2025 Management View CEO Chris Gibson highlighted the company's strategic focus on the Recursion Operating System 2.0, ...

AI coding assistants shine for boilerplate code, simple functions, documentation, debugging, and other routine tasks. Don’t ...